Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 13:15:1540643.
doi: 10.3389/fonc.2025.1540643. eCollection 2025.

Exosomes: their role and therapeutic potential in overcoming drug resistance of gastrointestinal cancers

Affiliations
Review

Exosomes: their role and therapeutic potential in overcoming drug resistance of gastrointestinal cancers

Jiulian Liu et al. Front Oncol. .

Abstract

Gastrointestinal cancers are prevalent malignant neoplasms in clinical medicine. The development of drug resistance in gastrointestinal cancers result in tumor recurrence and metastasis and greatly diminish the efficacy of treatment. Exosomes, as the shuttle of intercellular molecular cargoes in tumor micro-environment, secreted from tumor and stromal cells mediate drug resistance by regulating epithelial-mesenchymal transition, drug efflux, stem-like phenotype and cell metabolism. Meanwhile, exosomes have already received tremendous attention in biomedical study as potential drug resistant biomarkers as well as treatment strategy in gastrointestinal cancers. Primary challenge to implement this potential is the ability to obtain high-grade exosomes efficiently; however, exosomes lack standard protocols for their processing and characterization. Furthermore, this field suffers from insufficient standardized reference materials and workflow for purification, detection and analysis of exosomes with defined biological properties. This review summarize the unique biogenesis, composition and novel detection methods of exosomes and informed the underlying correlation between exosomes and drug resistance of gastrointestinal cancers. Moreover, the clinical applications of exosomes are also summarized, might providing novel therapy for the individual treatment of gastrointestinal cancers.

Keywords: biological function; clinical application; drug resistance; exosomes; gastrointestinal cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Biogenesis and composition of exosomes. The process of plasma membrane budding inward generates early endosomes. These endosomes are transformed into MVBs after sequestering specific cargos. Finally, the ILVs inside the MVBs are released outside the cell as exosomes. Exosomes contain various nucleic acids, proteins, and lipids, each with specific function. By Figdraw.
Figure 2
Figure 2
Microfluidics technologies for exosomes separation and detection flowchart. The figure shows the common methods for exosome isolation and detection based on microfluidics, and lists the respective advantages and disadvantages of each method.
Figure 3
Figure 3
Functional role of exosome contents in GI cancer drug resistance. Exosomal differential proteins and nucleic acids from different cells play an important role in the reversal of drug resistance, providing favorable conditions for further promoting individualized treatment of GI cancer. By Figdraw.
Figure 4
Figure 4
Potential Clinical Applications of Exosomes in GI Cancer drug resistance. Targeted inhibition of oncogenic exosomes through gene editing and pharmacological inhibitors and scavenging techniques. Delivery of therapeutic RNA or small molecule drugs to tumor cells via exosomes. Exosomes from various cells function as vaccines to activate anti-tumor immune responses. By Figdraw.

Similar articles

References

    1. Arnold M, Abnet CC, Neale RE, Vignat J, Giovannucci EL, McGlynn KA, et al. . Global burden of 5 major types of gastrointestinal cancer. Gastroenterology. (2020) 159:335–49.e15. doi: 10.1053/j.gastro.2020.02.068 - DOI - PMC - PubMed
    1. Tiwari AK, Laird-Fick HS, Wali RK, Roy HK. Surveillance for gastrointestinal Malignancies. World J Gastroenterol. (2012) 18:4507–16. doi: 10.3748/wjg.v18.i33.4507 - DOI - PMC - PubMed
    1. Dashti F, Mirazimi SMA, Rabiei N, Fathazam R, Rabiei N, Piroozmand H, et al. . The role of non-coding RNAs in chemotherapy for gastrointestinal cancers. Mol Ther Nucleic Acids. (2021) 26:892–926. doi: 10.1016/j.omtn.2021.10.004 - DOI - PMC - PubMed
    1. Bukowski K, Kciuk M, Kontek R. Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci. (2020) 21:3233. doi: 10.3390/ijms21093233 - DOI - PMC - PubMed
    1. Li L, Wang C, Li Q, Guan Y, Zhang X, Kong F, et al. . Exosomes as a modulator of immune resistance in human cancers. Cytok Growth Fact Rev. (2023) 73:135–49. doi: 10.1016/j.cytogfr.2023.07.007 - DOI - PubMed

LinkOut - more resources